GM11431
Amniotic fluid-derived cell line from Amniotic fluid
Description:
FRAGILE X MENTAL RETARDATION SYNDROME
Repository
|
NIGMS Human Genetic Cell Repository
|
Subcollection |
Heritable Diseases Chromosome Abnormalities |
Class |
Disorders with Trinucleotide Expansions |
Biopsy Source
|
Amniotic fluid
|
Cell Type
|
Amniotic fluid-derived cell line
|
Transformant
|
pSVori plasmid
|
Sample Source
|
Amniotic fluid-derived cell line from Amniotic fluid
|
Family Member
|
1
|
Relation to Proband
|
proband
|
Confirmation
|
Clinical summary/Case history
|
Species
|
Homo sapiens
|
Common Name
|
Human
|
Remarks
|
|
IDENTIFICATION OF SPECIES OF ORIGIN |
Species of Origin Confirmed by Nucleoside Phosphorylase, Glucose-6-Phosphate Dehydrogenase, and Lactate Dehydrogenase Isoenzyme Electrophoresis |
|
Remarks |
pSVori-transformed C5807 amniocyte cells; obligate carrier for fra(X); precrisis clone #1 expresses the fra(X) in 9% of cells; line is pseudodiploid, polyploid, & has rearrangements |
Jenkins LS, Gruenert DC, Jenkins EC, Schonberg SA, Transformation and establishment of fragile X cell lines from amniocytes. Am J Med Genet38:416-7 1991 |
PubMed ID: 1850193 |
Split Ratio |
1:3 |
Temperature |
37 C |
Percent CO2 |
5% |
Medium |
Amniotic Fluid Culture Medium |
Serum |
none Heat Inactivated |
Substrate |
None specified |
Subcultivation Method |
dilution - add fresh medium |
Supplement |
- |
|
|